Koru Medical Systems, Inc. (KRMD) Stock Price & Analysis
Koru Medical Systems, Inc. (KRMD) rose 0.93% to USD 3.25 as of September 8, 2026 at 11:21 UTC, according to Nexqual real-time market data.
KRMD last closed at USD 3.25; the session ranged USD 3.16–3.3 on volume of 116,640 shares. Market capitalization is —, with a 52-week range of USD 3.14–6.61 (NCM). Source: Nexqual, September 8, 2026 at 11:21 UTC.
Key Statistics (as of September 8, 2026 at 11:21 UTC)
| Price | USD 3.25 |
|---|---|
| Change | ▲ 0.93% (up) |
| Previous Close | USD 3.25 |
| Open | USD 3.25 |
| Day Range | USD 3.16 – 3.3 |
| 52-Week Range | USD 3.14 – 6.61 |
| Volume | 116,640 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (KRMD)
Nexqual's technical model rates KRMD "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 11:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.88 (neutral) |
| vs SMA50 | Below (USD 3.81) |
| MACD | -0.15 (negative) |
From Koru Medical Systems, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- The SCIg products administered by the FREEDOM System are indicated for a variety of conditions, including Primary Immunodeficiency Disease (PIDD ) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States and PIDD, CIDP and Secondary Immunodeficiency Disorder ("SIDD") outside of the United States.
- The use of the FREEDOM System for SCIg drug delivery continues to increase, and it remains the market leading delivery system in the U.S. for these treatments.
Partnerships
- The Company does not have any contracts with suppliers that impose material binding obligations on the Company or provide the Company with any material rights or benefits, other than the Company's agreement with Command.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IRMD | iRadimed Corporation | USD 83.45 | ▼ 3.16% |
| APYX | Apyx Medical Corporation | USD 3.05 | ▼ 0.97% |
| INFU | InfuSystems Holdings, Inc. | USD 12.24 | ▲ 0.82% |
| ELMD | Electromed, Inc. | USD 28 | ▼ 0.85% |
| TELA | TELA Bio, Inc. | USD 0.82 | ▲ 9.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 11:21 UTC. This page is informational and not investment advice.